Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/14238
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Van Heirstraeten, Liesbet | - |
dc.contributor.author | Coenen, Samuel | - |
dc.contributor.author | Lammens, Christine | - |
dc.contributor.author | HENS, Niel | - |
dc.contributor.author | Goossens, Herman | - |
dc.contributor.author | Malhotra-Kumar, Surbhi | - |
dc.date.accessioned | 2012-10-05T09:13:44Z | - |
dc.date.available | 2012-10-05T09:13:44Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | EMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518 | - |
dc.identifier.issn | 1080-6040 | - |
dc.identifier.uri | http://hdl.handle.net/1942/14238 | - |
dc.description.abstract | In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997-2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999-2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs. | - |
dc.description.sponsorship | This study was partly funded by the Belgian Antibiotic Policy Coordination Committee. | - |
dc.language.iso | en | - |
dc.publisher | CENTERS DISEASE CONTROL | - |
dc.subject.other | Immunology; Infectious Diseases | - |
dc.title | Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 1518 | - |
dc.identifier.issue | 9 | - |
dc.identifier.spage | 1515 | - |
dc.identifier.volume | 18 | - |
local.format.pages | 4 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Malhotra-Kumar, S (reprint author),[Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; Hens, Niel; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, B-2020 Antwerp, Belgium. [Hens, Niel] Univ Hasselt, Hasselt, Belgium. surbhi.malhotra@ua.ac.be | - |
local.publisher.place | ATLANTA | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.3201/eid1809.120049 | - |
dc.identifier.isi | 000307989700024 | - |
item.fulltext | With Fulltext | - |
item.contributor | Van Heirstraeten, Liesbet | - |
item.contributor | Coenen, Samuel | - |
item.contributor | Lammens, Christine | - |
item.contributor | HENS, Niel | - |
item.contributor | Goossens, Herman | - |
item.contributor | Malhotra-Kumar, Surbhi | - |
item.fullcitation | Van Heirstraeten, Liesbet; Coenen, Samuel; Lammens, Christine; HENS, Niel; Goossens, Herman & Malhotra-Kumar, Surbhi (2012) Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium. In: EMERGING INFECTIOUS DISEASES, 18 (9), p. 1515-1518. | - |
item.accessRights | Open Access | - |
item.validation | ecoom 2013 | - |
crisitem.journal.issn | 1080-6040 | - |
crisitem.journal.eissn | 1080-6059 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Antimicrobial drug use and macrolide-resistant streptococcus pyogenes, Belgium.pdf | Published version | 312.48 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.